Molecular pathways: Environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome

Clinical Cancer Research

Volumn 19, Issue 14, 2013, Pages 3732-3737

  Wong, Rebecca Lee Yean ^a   Walker, Cheryl Lyn ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; HISTONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR EZH2;

ARTICLE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; ENZYME INACTIVATION; EPIGENETICS; GENE ACTIVATION; GENE DISRUPTION; HISTONE METHYLATION; HUMAN; MOLECULAR GENETICS; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE SUSCEPTIBILITY; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; EPIGENESIS, GENETIC; ESTROGENS; GENOME, HUMAN; HUMANS; NEOPLASMS; RECEPTORS, ESTROGEN; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84881160372     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-0021     Document Type: Article

References (57)

1. Dong B, Cheng W, Li W, Zheng J, Wu D, Matsumura F, et al. FRET analysis of protein tyrosine kinase c-Src activation mediated via aryl hydrocarbon receptor. Biochim Biophys Acta 2011;1810: 427-31.
2. Faivre EJ, Lange CA. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Srcdependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol Cell Biol 2007;27:466-80.
3. Jimenez R, Sanchez M, Zarzuelo MJ, Romero M, Quintela AM, Lopez- Sepulveda R, et al. Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl- inositol-3 kinase-Akt pathway. J Pharmacol Exp Ther 2010; 332:554-61.
4. Sun M, Yang L, Feldman RI, Sun XM, Bhalla KN, Jove R, et al. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src. J Biol Chem 2003;278:42992-3000.
5. Watson CS, Alyea RA, Jeng YJ, Kochukov MY. Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues. Mol Cell Endocrinol 2007;274:1-7.
6. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 2001;8:269-80.
7. Gardner OS, Dewar BJ, Graves LM. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling. Mol Pharmacol 2005;68:933-41.
8. Sciullo EM, Vogel CF, Li W, Matsumura F. Initial and extended inflammatory messages of the nongenomic signaling pathway of the TCDDactivated Ah receptor in U937 macrophages. Arch Biochem Biophys 2008;480:143-55.
9. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 2007;282:22278-88.
10. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, et al. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell 2005;16:231-7.
11. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2002;2:489-501.
12. Zassadowski F, Rochette-Egly C, Chomienne C, Cassinat B. Regulation of the transcriptional activity of nuclear receptors by the MEK/ ERK1/2 pathway. Cell Signal 2012;24:2369-77.
13. Gilad LA, Schwartz B. Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor. J Mol Endocrinol 2007;38:603-18.
14. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, et al. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 2000;87:E44-52.
15. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol- Haseroth K, et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 2003;83:965-1016.
16. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol- 3-OH kinase. Nature 2000;407:538-41.
17. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, et al. PI3-kinase in concert with Src promotes the Sphase entry of oestradiol-stimulated MCF-7 cells. EMBO J 2001;20: 6050-9.
18. Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, et al. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res 2001;61: 5985-91.
19. Yu J, Akishita M, Eto M, Koizumi H, Hashimoto R, Ogawa S, et al. Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthase. Biochem Biophys Res Commun 2012;424:538-43.
20. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, et al. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 2000;19:5406-17.
21. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001;104:719-30.
22. Heinlein CA, Chang C. The roles of androgen receptors and androgenbinding proteins in nongenomic androgen actions. Mol Endocrinol 2002;16:2181-7.
23. Acconcia F, Kumar R. Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett 2006;238:1-14.
24. Keung W, Chan ML, Ho EY, Vanhoutte PM, Man RY. Non-genomic activation of adenylyl cyclase and protein kinaseGby 17beta-estradiol in vascular smooth muscle of the rat superior mesenteric artery. Pharmacol Res 2011;64:509-16.
25. Li X, Zhang S, Safe S. Activation of kinase pathways in MCF-7 cells by 17beta-estradiol and structurally diverse estrogenic compounds. J Steroid Biochem Mol Biol 2006;98:122-32.
26. Greathouse KL, Bredfeldt T, Everitt JI, Lin K, Berry T, Kannan K, et al. Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis. Mol Cancer Res 2012;10:546-57.
27. Bredfeldt TG, Greathouse KL, Safe SH, Hung MC, Bedford MT, Walker CL. Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT. Mol Endocrinol 2010;24:993-1006.
28. Bouskine A, Nebout M, Brucker-Davis F, Benahmed M, Fenichel P. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ Health Perspect 2009;117:1053-8.
29. Watson CS, Bulayeva NN, Wozniak AL, Alyea RA. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 2007;72:124-34.
30. Jeng YJ, Kochukov MY, Watson CS. Membrane estrogen receptoralpha- mediated nongenomic actions of phytoestrogens in GH3/B6/ F10 pituitary tumor cells. J Mol Signal 2009;4:2.
31. Bulayeva NN, Gametchu B, Watson CS. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membraneinitiated signaling pathways. Steroids 2004;69:181-92.
32. Liu D, Jiang H, Grange RW. Genistein activates the 30, 50-cyclic adenosine monophosphate signaling pathway in vascular endothelial cells and protects endothelial barrier function. Endocrinology 2005;146: 1312-20.
33. Liu D, Homan LL, Dillon JS. Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 50-monophosphate- dependent mechanism. Endocrinology 2004;145:5532-9.
34. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, et al. The G protein-coupled receptor GPR30 mediates c-fos upregulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 2004;279:27008-16.
35. Welshons WV, Nagel SC, vom Saal FS. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006;147:S56-69.
36. Verkasalo PK, Appleby PN, Davey GK, Key TJ. Soy milk intake and plasma sex hormones: a cross-sectional study in pre- and postmenopausal women (EPIC-Oxford). Nutr Cancer 2001;40:79-86.
37. De Coster S, van Larebeke N. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health 2012;2012:713696.
38. Greathouse KL, Cook JD, Lin K, Davis BJ, Berry TD, Bredfeldt TG, et al. Identification of uterine leiomyoma genes developmentally reprogrammed by neonatal exposure to diethylstilbestrol. Reprod Sci 2008;15:765-78.
39. Cook JD, Davis BJ, Cai SL, Barrett JC, Conti CJ, Walker CL. Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc Natl Acad Sci U S A 2005;102:8644-9.
40. Walker CL, Ho SM. Developmental reprogramming of cancer susceptibility. Nat Rev Cancer 2012;12:479-86.
41. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293:1074-80.
42. Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007;25:1-14.
43. Cha TL, Zhou BP, Xia W, Wu Y, Yang CC, Chen CT, et al. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 2005;310:306-10.
44. Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, et al. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gammatransactivation. Nat Cell Biol 2007;9:1273-85.
45. Sen N, Snyder SH. Neurotrophin-mediated degradation of histone methyltransferase by S-nitrosylation cascade regulates neuronal differentiation. Proc Natl Acad Sci U S A 2011;108:20178-83.
46. Wu S, Wang W, Kong X, Congdon LM, Yokomori K, Kirschner MW, et al. Dynamic regulation of thePR-Set7 histonemethyltransferase is required for normal cell cycle progression. Genes Dev 2010;24:2531-42.
47. Boeke J, Regnard C, Cai W, Johansen J, Johansen KM, Becker PB, et al. Phosphorylation of SU(VAR)3-9 by the chromosomal kinase JIL-1. PLoS ONE 2010;5:e10042.
48. Wu SC, Zhang Y. Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability. J Biol Chem 2011;286:28511-9.
49. Feng Q, He B, Jung SY, Song Y, Qin J, Tsai SY, et al. Biochemical control of CARM1 enzymatic activity by phosphorylation. J Biol Chem 2009;284:36167-74.
50. Ogawa M, Hiraoka Y, Aiso S. The Polycomb-group protein ENX-2 interacts with ZAP-70. Immunol Lett 2003;86:57-61.
51. Lan F, Nottke AC, Shi Y. Mechanisms involved in the regulation of histone lysine demethylases. Curr Opin Cell Biol 2008;20:316-25.
52. Baba A, Ohtake F, Okuno Y, Yokota K, Okada M, Imai Y, et al. PKAdependent regulation of the histone lysine demethylase complex PHF2-ARID5B. Nat Cell Biol 2011;13:668-75.
53. Liu W, Tanasa B, Tyurina OV, Zhou TY, Gassmann R, Liu WT, et al. PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature 2010;466:508-12.
54. Liang CY, Hsu PH, Chou DF, Pan CY, Wang LC, Huang WC, et al. The histone H3K36 demethylase Rph1/KDM4 regulates the expression of the photoreactivation gene PHR1. Nucleic Acids Res 2011;39: 4151-65.
55. Lomberk G, Bensi D, Fernandez-Zapico ME, Urrutia R. Evidence for the existence of an HP1-mediated subcode within the histone code. Nat Cell Biol 2006;8:407-15.
56. Ayoub N, Jeyasekharan AD, Bernal JA, Venkitaraman AR. HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response. Nature 2008;453:682-6.
57. Sun Y, Jiang X, Xu Y, Ayrapetov MK, Moreau LA, Whetstine JR, et al. Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60. Nat Cell Biol 2009;11:1376-82.